Holen Sie sich die Stockscreener-App
1.40
6.06%
0.08
Bioatla Inc Aktie (BCAB) Neueste Nachrichten
Bioatla Stock Price Forecast. Should You Buy BCAB? - StockInvest.us
BioAtla (BCAB) CMO has RSU shares withheld for taxes - Stock Titan
BioAtla (BCAB) CEO still holds 52,035 shares after tax withholding - Stock Titan
BioAtla (BCAB) CFO’s stock move is a tax withholding, not a sale - Stock Titan
BioAtla, Inc. Financial Disclosures & SEC Filings - TradingView
Book value per share of BioAtla, Inc. – OTC:BCAB - TradingView
BioAtla, Inc. Actuals & Estimates (OTC:BCAB) - TradingView
BioAtla, Inc.(NasdaqCM: BCAB) dropped from S&P TMI Index - marketscreener.com
Diluted shares outstanding of BioAtla, Inc. – OTC:BCAB - TradingView
Net current asset value per share of BioAtla, Inc. – OTC:BCAB - TradingView
Price to cash flow ratio of BioAtla, Inc. – OTC:BCAB - TradingView
Enterprise value to EBIT forward of BioAtla, Inc. – OTC:BCAB - TradingView
Enterprise value to EBITDA forward of BioAtla, Inc. – OTC:BCAB - TradingView
Enterprise value to EBITDA ratio of BioAtla, Inc. – OTC:BCAB - TradingView
EBITDA margin % of BioAtla, Inc. – OTC:BCAB - TradingView
Cost of goods sold of BioAtla, Inc. – OTC:BCAB - TradingView
Operating expenses (excl. COGS) of BioAtla, Inc. – OTC:BCAB - TradingView
Operating income of BioAtla, Inc. – OTC:BCAB - TradingView
Diluted earnings per share (diluted EPS) of BioAtla, Inc. – OTC:BCAB - TradingView
After tax other income/expense of BioAtla, Inc. – OTC:BCAB - TradingView
Cash flow from investing activities of BioAtla, Inc. – OTC:BCAB - TradingView
Cash flow from operating activities of BioAtla, Inc. – OTC:BCAB - TradingView
Average basic shares outstanding of BioAtla, Inc. – OTC:BCAB - TradingView
Free cash flow of BioAtla, Inc. – OTC:BCAB - TradingView
Non-controlling/minority interest of BioAtla, Inc. – OTC:BCAB - TradingView
Total revenue of BioAtla, Inc. – OTC:BCAB - TradingView
Cash flow from financing activities of BioAtla, Inc. – OTC:BCAB - TradingView
Gross profit of BioAtla, Inc. – OTC:BCAB - TradingView
Net income before discontinued operations of BioAtla, Inc. – OTC:BCAB - TradingView
Dilution adjustment of BioAtla, Inc. – OTC:BCAB - TradingView
Non-operating income (total) of BioAtla, Inc. – OTC:BCAB - TradingView
Total debt of BioAtla, Inc. – OTC:BCAB - TradingView
BioAtla, Inc. Cash Flow – OTC:BCAB - TradingView
Total equity of BioAtla, Inc. – OTC:BCAB - TradingView
Net debt of BioAtla, Inc. – OTC:BCAB - TradingView
BioAtla, Inc. Statistics – OTC:BCAB - TradingView
BioAtla, Inc. Balance Sheet – OTC:BCAB - TradingView
BioAtla, Inc. Earnings and Revenue – OTC:BCAB - TradingView
BioAtla, Inc. Revenue Breakdown – OTC:BCAB - TradingView
Net income of BioAtla, Inc. – OTC:BCAB - TradingView
BioAtla, Inc. Financial Statements – OTC:BCAB - TradingView
ETFs Investing in BioAtla, Inc. Stocks - TradingView
BioAtla, Inc. Income Statement – OTC:BCAB - TradingView
Free float of BioAtla, Inc. – OTC:BCAB - TradingView
Price to earnings ratio of BioAtla, Inc. – OTC:BCAB - TradingView
Basic earnings per share (basic EPS) of BioAtla, Inc. – OTC:BCAB - TradingView
BCAB Stock Price and Chart — OTC:BCAB - TradingView
BioAtla (BCAB) Holds Steady at $1.74 as Biotech Stock Consolidates Between Key LevelsHedge Fund Favorites - vinanet.vn
BCAB Q4 2025 Earnings: Narrower-Than-Expected Loss Fails to Halt 44.75% SlideEarnings Outlook Update - vinanet.vn
BioAtla Faces Nasdaq Delisting After Losing Final Appeal - Minichart
BioAtla Faces Nasdaq Delisting, Plans OTC Market Move - TipRanks
BioAtla Received Notice of Delisting - TradingView
BioAtla, Inc.(OTCPK: BCAB) dropped from NASDAQ Composite Index - marketscreener.com
BioAtla (BCAB) Quarterly Figures: The EPS Result Is Above Expectation on the Day; Post-Report: The Share Price Moves Only Slightly in the Latest SessionFull Year Guidance - vinanet.vn
BioAtla (BCAB) Financial Results: The Bottom-Line Figure Outpaces Its Comparison in the Latest Reading; Investor Response: Shares Finish 3.46% Higher in the Latest SessionWeak Earnings Momentum - vinanet.vn
BioAtla Inc. (BCAB) Tumbles 10.4% to $3.09 as Bearish Momentum Tests Key $2.94 SupportTurnaround Stocks - Vinanet
BioAtla, Inc. Q2 2026: Revenue $6.5M, EPS $0.27— 10-Q Summary - TradingView
BioAtla (BCAB) turns Q2 2026 profit as cash falls and going concern risk emerges - Stock Titan
BioAtla, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Bioatla Inc (BCAB) Stock News Today - TradingKey
Bioatla Inc (BCAB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BioAtla (BCAB) Climbs 3.9% to $3.46 as Buyers Step In Near SupportButterfly Setup - Vinanet
BCAB Q2'26 Earnings: EPS estimate is (8.50) USD - TradingView
BioAtla Inc. (BCAB) Slips 2.37% to $3.3 as Shares Hover Near Key Support at $3.13Quality ETF - vinanet.vn
BCAB Q4 2025 Earnings: EPS Beat Signals Tightened Cash Management Amid No Revenue MilestonesOne-Time Gain Impact - vinanet.vn
BCAB|Bioatla Inc|Price:3.460|Chg%:+0.130 - TradingKey
BioAtla (BCAB) Slips 3.76% as Shares Approach Critical Support ZoneHagopian Line - dars.gov.et
Bioatla Inc (BCAB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Bioatla Inc (BCAB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bioatla Inc (BCAB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Bioatla Inc (BCAB) Valuation: PE, PB & Fair Value Analysis - TradingKey
Bioatla Inc (BCAB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
0.71%
2.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):